391 related articles for article (PubMed ID: 14522114)
1. Preparation and in-vitro release rate of fentanyl-cyclodextrin complexes for prolonged action in epidural analgesia.
Holvoet C; Plaizier-Vercammen J; Vander Heyden Y; Gabriëls M; Camu F
Int J Pharm; 2003 Oct; 265(1-2):13-26. PubMed ID: 14522114
[TBL] [Abstract][Full Text] [Related]
2. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
[TBL] [Abstract][Full Text] [Related]
3. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
Holvoet C; Heyden YV; Plaizier-Vercammen J
Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403
[TBL] [Abstract][Full Text] [Related]
4. Cyclodextrin-catalyzed deacetylation of spironolactone is pH and cyclodextrin dependent.
Jarho P; Vander Velde D; Stella VJ
J Pharm Sci; 2000 Feb; 89(2):241-9. PubMed ID: 10688753
[TBL] [Abstract][Full Text] [Related]
5. Influence of preparation method on itraconazole oral solutions using cyclodextrins as complexing agents.
Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
Pharmazie; 2007 Jul; 62(7):510-4. PubMed ID: 17718191
[TBL] [Abstract][Full Text] [Related]
6. Interaction of fentanyl with various cyclodextrins in aqueous solutions.
Ogawa N; Furuishi T; Nagase H; Endo T; Takahashi C; Yamamoto H; Kawashima Y; Loftsson T; Kobayashi M; Ueda H
J Pharm Pharmacol; 2016 May; 68(5):588-97. PubMed ID: 26077960
[TBL] [Abstract][Full Text] [Related]
7. Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-beta-CD to HP-beta-CD.
Zia V; Rajewski RA; Stella VJ
Pharm Res; 2001 May; 18(5):667-73. PubMed ID: 11465424
[TBL] [Abstract][Full Text] [Related]
8. Design and evaluation of an osmotic pump tablet (OPT) for chlorpromazine using (SBE)7m-beta-CD.
Okimoto K; Ohike A; Ibuki R; Aoki O; Ohnishi N; Irie T; Uekama K; Rajewski RA; Stella VJ
Pharm Res; 1999 Apr; 16(4):549-54. PubMed ID: 10227711
[TBL] [Abstract][Full Text] [Related]
9. Study on the inclusion complexes of bromazepam with beta- and beta-hydroxypropyl-cyclodextrins.
Archontaki HA; Vertzoni MV; Athanassiou-Malaki MH
J Pharm Biomed Anal; 2002 May; 28(3-4):761-9. PubMed ID: 12008156
[TBL] [Abstract][Full Text] [Related]
10. Hydroxypropyl-beta-cyclodextrin increases the aqueous solubility and stability of pilocarpine prodrugs.
Jarho P; Urtti A; Järvinen T
Pharm Res; 1995 Sep; 12(9):1371-5. PubMed ID: 8570537
[TBL] [Abstract][Full Text] [Related]
11. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
[TBL] [Abstract][Full Text] [Related]
12. Osmotic properties of sulfobutylether and hydroxypropyl cyclodextrins.
Zannou EA; Streng WH; Stella VJ
Pharm Res; 2001 Aug; 18(8):1226-31. PubMed ID: 11587496
[TBL] [Abstract][Full Text] [Related]
13. [Dissolution of nimodipine in an aqueous solution of hydroxyethyl-beta-cyclodextrin and a review of solubility of nimodipine with cyclodextrins].
Kopecký F; Kopecká B; Kaclík P
Ceska Slov Farm; 2003 Jan; 52(1):33-8. PubMed ID: 12685332
[TBL] [Abstract][Full Text] [Related]
14. Improved bioavailability of a water-insoluble drug by inhalation of drug-containing maltosyl-β-cyclodextrin microspheres using a four-fluid nozzle spray drier.
Ozeki T; Kano Y; Takahashi N; Tagami T; Okada H
AAPS PharmSciTech; 2012 Dec; 13(4):1130-7. PubMed ID: 22945234
[TBL] [Abstract][Full Text] [Related]
15. Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.
Suihko E; Korhonen O; Järvinen T; Ketolainen J; Jarho P; Laine E; Paronen P
Int J Pharm; 2001 Mar; 215(1-2):137-45. PubMed ID: 11250099
[TBL] [Abstract][Full Text] [Related]
16. Interaction of iodine with 2-hydroxypropyl-alpha-cyclodextrin and its bactericidal activity.
Tomono K; Goto H; Suzuki T; Ueda H; Nagai T; Watanabe J
Drug Dev Ind Pharm; 2002 Nov; 28(10):1303-9. PubMed ID: 12476876
[TBL] [Abstract][Full Text] [Related]
17. Development of an omeprazole parenteral formulation with hydroxypropyl-beta-cyclodextrin.
Holvoet C; Heyden YV; Plaizier-Vercammen J
Pharm Dev Technol; 2007; 12(3):327-36. PubMed ID: 17613896
[TBL] [Abstract][Full Text] [Related]
18. Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-beta-cyclodextrin as both a solubilizing and an osmotic pump agent.
Okimoto K; Rajewski RA; Stella VJ
J Control Release; 1999 Mar; 58(1):29-38. PubMed ID: 10021487
[TBL] [Abstract][Full Text] [Related]
19. Optimized transdermal delivery of ketoprofen using pH and hydroxypropyl-beta-cyclodextrin as co-enhancers.
Sridevi S; Diwan PV
Eur J Pharm Biopharm; 2002 Sep; 54(2):151-4. PubMed ID: 12191685
[TBL] [Abstract][Full Text] [Related]
20. Solubilization and stabilization of sodium dicloxacillin by cyclodextrin inclusion.
Echezarreta-López MM; Otero-Mazoy I; Ramírez HL; Villalonga R; Torres-Labandeira JJ
Curr Drug Discov Technol; 2008 Jun; 5(2):140-5. PubMed ID: 18673252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
